XTLB — XTL BIOPHARMACEUTICALS LTD
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1023549 ·
Last close
$2.20
Market Cap
$5.41M
52W High
$10.28
52W Low
$2.01
ADV30
8,330
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2025 | — | — | — | — | 166,000 | 76,000 | 420,000 |
| Jun 2025 | — | — | — | — | 714,000 | 150,000 | 761,000 |
| Dec 2024 | 289,000 | -43,000 | -812,000 | -255,000 | 8,550,000 | 371,000 | 3,115,000 |
| Sep 2024 | 162,000 | — | -764,000 | -553,000 | 9,280,000 | 820,000 | 3,563,000 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-165,632,000
Inventory
—
Receivables
$0
ST Investments
$68,000
EBIT TTM
$-479,000
Pretax Income TTM
$-385,000
Interest Exp TTM
$-94,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$968,000
EBITDA
$-1,266,000
Free Cash Flow
$-2,116,000
Enterprise Value
$6,212,649
Total Cash
$76,000
Total Debt
$0
Shares Out
2,457,463
Trailing EPS
$-0.36
Book Value
$0.00
ROE
-29.3%
ROA
-21.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -1,380,000 | -6,969,000 | 166,000 | 420,000 | -254,000 | -1,025,000 |
| Dec 2024 | 0 | -775,000 | -1,027,000 | 8,550,000 | 3,115,000 | 5,435,000 | -1,618,000 |
| Dec 2023 | 0 | -765,000 | -1,782,000 | 2,430,000 | 206,000 | 2,220,000 | -707,000 |
| Dec 2022 | 0 | -880,000 | -1,348,000 | 4,190,000 | 187,000 | 3,999,000 | -901,000 |
| Dec 2021 | — | — | — | — | — | — | — |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| NCNA | NuCana plc | $5.33M | $1.28 | — |
| INBP | INTEGRATED BIOPHARMA INC | $5.59M | $0.18 | — |
| XBIO | Xenetic Biosciences, Inc. | $5.60M | $2.39 | — |
| DRMA | Dermata Therapeutics, Inc. | $5.65M | $1.14 | — |
| PCSA | Processa Pharmaceuticals, Inc. | $5.14M | $1.84 | — |
News headlines (Yahoo Finance, 1h cache)
XTL Completed the Acquisition of Psyga Bio Ltd.
2026-06-30 21:15 · Yahoo
XTL Announces Receipt of Staff Delist Determination from Nasdaq
2026-05-22 20:10 · Yahoo
XTL Biopharmaceuticals to Acquire Psyga Bio, Establishing a Leading Psychedelic Biotechnology Platform with Advanced Clinical Pipeline, Licensed GMP Manufacturing and Proprietary Psilocybin Technologi
2026-04-29 12:58 · Yahoo
XTL Biopharmaceuticals Announces ADS Ratio Change
2026-03-20 20:10 · Yahoo
XTL Update on Recent Developments
2026-01-29 21:05 · Yahoo
Top Midday Gainers
2026-01-13 18:54 · Yahoo
XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership
2026-01-13 14:28 · Yahoo
XTL Biopharmaceuticals Acquires 85% of Beyond Air’s Subsidiary NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership
2026-01-13 12:30 · Yahoo
XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
2025-12-24 21:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.